Core Viewpoint - Qiaoyuan Co., Ltd. has obtained a production license for medical liquid oxygen, which is expected to enhance its competitiveness in the pharmaceutical sector and positively impact its future operations [1] Group 1: Company Developments - Qiaoyuan's wholly-owned subsidiary, Qiaoyuan (Jintang) Gas Co., Ltd., has recently received the approval from the Sichuan Provincial Drug Administration for the renewal of its "Drug Production License" [1] - The production scope has been changed to include medical gases, specifically liquid oxygen, after passing the GMP compliance inspection [1] - This change is anticipated to expand the company's production and sales of medical oxygen products [1] Group 2: Industry Impact - The approval is expected to enhance the company's competitiveness in the pharmaceutical field [1] - The positive implications for the company's future operations are highlighted, indicating a strategic move within the medical gas industry [1]
侨源股份：全资子公司取得医用液氧药品生产许可证